Quarterly Results

NURECA LTD.

NSE : NURECABSE : 543264ISIN CODE : INE0DSF01015Industry : Medical Equipment/Supplies/AccessoriesHouse : Private
BSE289.90-3.35 (-1.14 %)
PREV CLOSE ( ) 293.25
OPEN PRICE ( ) 292.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5946
TODAY'S LOW / HIGH ( )286.00 297.00
52 WK LOW / HIGH ( )252.4 468.25
NSE288.95-3.75 (-1.28 %)
PREV CLOSE( ) 292.70
OPEN PRICE ( ) 294.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 288.95 (12)
VOLUME 18542
TODAY'S LOW / HIGH( ) 286.25 297.35
52 WK LOW / HIGH ( )253.5 468.8
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
223.74
313.53
212.31
212.26
Total Expenditure
266.29
299.68
241.34
246.82
PBIDT (Excl OI)
-42.55
13.85
-29.03
-34.56
Other Income
59.01
31.99
26.73
21.48
Operating Profit
16.46
45.84
-2.30
-13.08
Interest
1.1
0.84
1.16
1.04
Exceptional Items
NA
NA
NA
NA
PBDT
15.36
45
-3.46
-14.12
Depreciation
5.91
5.88
5.83
5.61
Profit Before Tax
9.44
39.12
-9.29
-19.73
Tax
7.8
10.18
-2.22
-4.43
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1.64
28.94
-7.07
-15.3
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1.64
28.94
-7.07
-15.3
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1.65
28.94
-7.07
-15.3
Equity Capital
100
100
100
100
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
0.16
2.89
-0.70
-1.53
Calculated EPS (Annualised)
0.66
11.57
-2.82
-6.12
No of Public Share Holdings
3676534
3676534
3701734
3701734
% of Public Share Holdings
36.76
36.76
37.02
37.02
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-19.01
4.41
-13.67
-16.28
PBIDTM%
7.35
14.62
-1.08
-6.16
PBDTM%
6.86
14.35
-1.62
-6.65
PBTM%
4.22
12.47
-4.37
-9.29
PATM%
0.73
9.23
-3.33
-7.20
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.